Melatoninergic system in Parkinson’s disease: from neuroprotection to the management of motor and nonmotor symptoms (2016)
- Authors:
- Mack, Josiel Mileno - Universidade Federal de Santa Catarina (UFSC)
- Schamne, Marissa Giovanna - Universidade Federal de Santa Catarina (UFSC)
- Sampaio, Tuane Bazanella - Universidade Federal de Santa Catarina (UFSC)
- Pértile, Renata Aparecida Nedel
- Fernandes, Pedro Augusto Carlos Magno
- Markus, Regina P
- Prediger, Rui Daniel - Universidade Federal de Santa Catarina (UFSC)
- USP affiliated authors: FERNANDES, PEDRO AUGUSTO CARLOS MAGNO - IB ; MARKUS, REGINA PEKELMANN - IB
- Unidade: IB
- DOI: 10.1155/2016/3472032
- Subjects: DOENÇA DE PARKINSON; MELATONINA; DOENÇAS NEURODEGENERATIVAS; AGENTES DOPAMINÉRGICOS; ANTIOXIDANTES; NEUROCIÊNCIAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Oxidative Medicine and Cellular Longevity
- ISSN: 1942-0994
- Volume/Número/Paginação/Ano: v. 2016, p. 1-31, art. ID 3472032, 2016
- Status:
- Artigo aberto em periódico híbrido (Hybrid Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
MACK, Josiel Mileno et al. Melatoninergic system in Parkinson’s disease: from neuroprotection to the management of motor and nonmotor symptoms. Oxidative Medicine and Cellular Longevity, v. 2016, p. 1-31, 2016Tradução . . Disponível em: https://doi.org/10.1155/2016/3472032. Acesso em: 01 abr. 2026. -
APA
Mack, J. M., Schamne, M. G., Sampaio, T. B., Pértile, R. A. N., Fernandes, P. A. C. M., Markus, R. P., & Prediger, R. D. (2016). Melatoninergic system in Parkinson’s disease: from neuroprotection to the management of motor and nonmotor symptoms. Oxidative Medicine and Cellular Longevity, 2016, 1-31. doi:10.1155/2016/3472032 -
NLM
Mack JM, Schamne MG, Sampaio TB, Pértile RAN, Fernandes PACM, Markus RP, Prediger RD. Melatoninergic system in Parkinson’s disease: from neuroprotection to the management of motor and nonmotor symptoms [Internet]. Oxidative Medicine and Cellular Longevity. 2016 ; 2016 1-31.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1155/2016/3472032 -
Vancouver
Mack JM, Schamne MG, Sampaio TB, Pértile RAN, Fernandes PACM, Markus RP, Prediger RD. Melatoninergic system in Parkinson’s disease: from neuroprotection to the management of motor and nonmotor symptoms [Internet]. Oxidative Medicine and Cellular Longevity. 2016 ; 2016 1-31.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1155/2016/3472032 - Amyloid b peptide directly impairs pineal gland melatonin synthesis and melatonin receptor signaling through the ERK pathway
- Long-lasting priming of endothelial cells by plasma melatonin levels
- Melatonin and inflammation: the role of the immune-pineal axis and sympathetic tonus
- The Concept of the Immune-Pineal Axis Tested in Patients Undergoing an Abdominal Hysterectomy
- Effects of acute hypothyroidism on plasma melatonin and Aanat and Asmt expression in the pineal gland and gonads of rats
- Daily corticosterone rhythm modulates pineal function through NFκB-related gene transcriptional program
- Expression of the Circadian Clock Gene BMAL1 Positively Correlates With Antitumor Immunity and Patient Survival in Metastatic Melanoma
- Daily variation of constitutively activated nuclear factor kappa B (NFKB) in rat pineal gland
- TLR4 and CD14 receptors expressed in rat pineal gland trigger NFKB pathway
- Daily rhythm of salivary IL-beta, cortisol and melatonin in day and night-workers
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
